Henoch-Schonlein purpura, although it sounds like an ordinary allergic reaction, can be life-threatening if left untreated! Today, we're bringing in experts to uncover the truth behind this potential health threat.
Henoch-Schonlein purpura is a systemic hemorrhagic inflammation of small blood vessels caused by an abnormal immune system, which is mainly manifested as skin purpura, joint pain, abdominal pain and kidney damage. Although most cases are self-limiting, if left untreated and managed, the condition can deteriorate rapidly, with serious consequences.
First, kidney damage is one of the most common and serious complications of Henoch-Schonlein purpura. Untreated Henoch-Schonlein purpura can lead to glomerulonephritis, which manifests as hematuria, proteinuria, and in severe cases, acute renal failure. Severe impairment of kidney function not only affects detoxification function, but also leads to electrolyte imbalances and high blood pressure in the body, which is further life-threatening.
Secondly, gastrointestinal bleeding is also a major risk for people with Henoch-Schonlein purpura. Due to the effects of inflammation of small blood vessels, the mucosa of the gastrointestinal tract may ulcerate and bleed. Severe gastrointestinal bleeding can lead to anemia, shock, and even fatal bleeding. If not detected and treated in time, patients can be in danger of their lives.
In addition, Henoch-Schonlein purpura may affect other vital organ systems, such as the heart and central nervous system. Cardiac involvement may cause myocarditis, leading to heart failure or arrhythmias. Involvement of the central nervous system may lead to serious complications such as intracerebral hemorrhage and seizures. When these situations occur, they pose a direct threat to life.
Experts remind that early detection and timely treatment are key to coping with Henoch-Schonlein purpura. Symptoms such as skin purpura, joint pain, and abdominal pain should be noticed immediately. Doctors usually do blood tests, urine tests, and imaging tests to confirm and evaluate the condition. Treatment includes anti-inflammatory drugs, immunosuppressants, and, if necessary, supportive care, such as dialysis and blood transfusions.
In daily life, parents and patients should pay special attention to preventing infection, maintaining good living habits, eating reasonably, exercising moderately, and enhancing immunity. At the same time, regular check-ups, close monitoring of changes in the condition, and timely adjustment of the treatment plan to avoid deterioration of the condition.
Although Henoch-Schonlein purpura may seem ordinary, if left untreated, it can lead to fatal complications. It is hoped that through this article, more people can realize the potential harm of Henoch-Schonlein purpura, detect it early, respond scientifically, and jointly protect life and health. Let's work hard for the recovery and health of every patient!